Long Noncoding RNAs as Biomarkers For Prostate Cancer Detection

Long Noncoding RNAs as Biomarkers For Prostate Cancer Detection
A group of researchers from the Sanford-Burnham Medical Research Institute in Orlando, FL, have found an RNA biomarker detectable in prostate cancer patients’ urine and tissue samples. There is an unmet need to develop efficient, sensitive and specific biomarkers that allow for an early detection of prostate cancer, this way reducing overtreatment and associated mortality.

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *